Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

About Rob Michiels

Rob Michiels is a 30-year U.S. veteran of the medical device industry. He most recently served as chief operating officer (COO) of CoreValve; and President and COO of InterVentional Technologies. Rob Michiels is a director of CardiAQ Valve Technologies, a privately held company based in Winchester, Massachusets. Rob Michiels is a founding partner of CONSILIUM, a medical device market research company active in identifying, funding and greenhousing start-up technologies. Fluent in English, French and Dutch languages, he holds a bachelor's degree in economics from Antwerp University in Belgium and a Masters in business administration (MBA) from Indiana University.

Rob Michiels Headquarter Location

Fallbrook, California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Rob Michiels News

FEops elects Rob Michiels as Chairman

Sep 19, 2016

News » 2016 » 09 » 16 » FEops elects Rob Michiels as Chairman FEops elects Rob Michiels as Chairman Former CardiAQ Valve Technologies CEO and CoreValve COO says FEops' "predictive procedure-planning platform" may be crucial to the ultimate-outcome success of transcatheter-based valve therapies "Certainly, Rob Michiels is one of the most experienced, most successful executives in the cardiovascular industry. " Matthieu De Beule, PhD, CEO, FEops Ghent, Belgium: 16 September 2016 - FEops, which is developing "future-generation planning technology for transcatheter valve therapies", today announced that it has elected Rob Michiels to serve as Chairman of the Board of Directors, effectively immediately. Until September 2015, Michiels was Chief Executive Officer at CardiAQ Valve Technologies, the Transcatheter Mitral Valve Replacement (TMVR) company, which was acquired by Edwards Lifesciences. More info on FEops ' website.

Rob Michiels Investments

1 Investments

Rob Michiels has made 1 investments. Their latest investment was in CardiAQ Valve Technologies as part of their Series A on January 1, 2010.

CBI Logo

Rob Michiels Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/20/2010

Series A

CardiAQ Valve Technologies

$6.5M

Yes

Date

1/20/2010

Round

Series A

Company

CardiAQ Valve Technologies

Amount

$6.5M

New?

Yes

Co-Investors

Sources

Rob Michiels Portfolio Exits

1 Portfolio Exit

Rob Michiels has 1 portfolio exit. Their latest portfolio exit was CardiAQ Valve Technologies on July 10, 2015.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/10/2015

Acquired

$99M

1

Date

7/10/2015

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.